Jiřı́ Hatina

2.4k total citations
38 papers, 906 citations indexed

About

Jiřı́ Hatina is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jiřı́ Hatina has authored 38 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Surgery. Recurrent topics in Jiřı́ Hatina's work include Cancer Cells and Metastasis (10 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Epigenetics and DNA Methylation (6 papers). Jiřı́ Hatina is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Epigenetics and DNA Methylation (6 papers). Jiřı́ Hatina collaborates with scholars based in Czechia, Germany and Austria. Jiřı́ Hatina's co-authors include Wolfgang A. Schulz, Martin Richards, Luı́sa Pereira, Dominik Wolf‎, Sieghart Sopper, Alain G. Zeimet, Maximilian Boesch, Daniel Reimer, Vincent Macaulay and Rainer Engers and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Jiřı́ Hatina

36 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiřı́ Hatina Czechia 16 475 251 225 184 125 38 906
Amanda J. Russell Australia 16 571 1.2× 238 0.9× 134 0.6× 129 0.7× 40 0.3× 27 789
Raed Samara United States 12 386 0.8× 664 2.6× 183 0.8× 245 1.3× 52 0.4× 15 1.0k
Gillian Hutchinson United Kingdom 10 255 0.5× 139 0.6× 16 0.1× 58 0.3× 60 0.5× 16 496
Patricia F. van Kuijk Netherlands 10 580 1.2× 60 0.2× 101 0.4× 450 2.4× 35 0.3× 11 769
David N. Boone United States 12 540 1.1× 203 0.8× 100 0.4× 189 1.0× 23 0.2× 26 753
Nobuaki Akakura United States 7 328 0.7× 154 0.6× 67 0.3× 311 1.7× 40 0.3× 9 596
Ulrike Schwarz‐Boeger Germany 10 401 0.8× 172 0.7× 215 1.0× 167 0.9× 39 0.3× 23 739
René Figueredo Canada 14 261 0.5× 321 1.3× 37 0.2× 44 0.2× 56 0.4× 33 669
Amel Saadi United Kingdom 6 360 0.8× 199 0.8× 118 0.5× 105 0.6× 91 0.7× 8 574
Christiane Hader Germany 16 688 1.4× 150 0.6× 112 0.5× 214 1.2× 84 0.7× 19 857

Countries citing papers authored by Jiřı́ Hatina

Since Specialization
Citations

This map shows the geographic impact of Jiřı́ Hatina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiřı́ Hatina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiřı́ Hatina more than expected).

Fields of papers citing papers by Jiřı́ Hatina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiřı́ Hatina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiřı́ Hatina. The network helps show where Jiřı́ Hatina may publish in the future.

Co-authorship network of co-authors of Jiřı́ Hatina

This figure shows the co-authorship network connecting the top 25 collaborators of Jiřı́ Hatina. A scholar is included among the top collaborators of Jiřı́ Hatina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiřı́ Hatina. Jiřı́ Hatina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatina, Jiřı́, et al.. (2021). Pluripotency Stemness and Cancer: More Questions than Answers. Advances in experimental medicine and biology. 1376. 77–100. 8 indexed citations
2.
Mezheyeuski, Artur, Ulrika Segersten, Lina Leiss, et al.. (2020). Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome. Scientific Reports. 10(1). 281–281. 44 indexed citations
3.
Kripnerová, Michaela, Hamendra Singh Parmar, Martin Pešta, et al.. (2019). Urothelial Cancer Stem Cell Heterogeneity. Advances in experimental medicine and biology. 1139. 127–151. 8 indexed citations
4.
Hatina, Jiřı́, Michaela Kripnerová, Martin Pešta, et al.. (2019). Sarcoma Stem Cell Heterogeneity. Advances in experimental medicine and biology. 1123. 95–118. 39 indexed citations
5.
Hatina, Jiřı́, Maximilian Boesch, Sieghart Sopper, et al.. (2019). Ovarian Cancer Stem Cell Heterogeneity. Advances in experimental medicine and biology. 1139. 201–221. 28 indexed citations
6.
Pereira, Joana B., Marta D. Costa, Daniel Vieira, et al.. (2017). Reconciling evidence from ancient and contemporary genomes: a major source for the European Neolithic within Mediterranean Europe. Proceedings of the Royal Society B Biological Sciences. 284(1851). 20161976–20161976. 18 indexed citations
7.
Hatina, Jiřı́, Hamendra Singh Parmar, Michaela Kripnerová, Anastasia C. Hepburn, & Rakesh Heer. (2017). Urothelial Carcinoma Stem Cells: Current Concepts, Controversies, and Methods. Methods in molecular biology. 1655. 121–136. 10 indexed citations
8.
Hatina, Jiřı́, Michaela Kripnerová, Pavel Dvořák, et al.. (2015). Tumor-Stroma-Interaktionen im Harnblasenkarzinom. Der Urologe. 54(4). 516–525. 3 indexed citations
9.
Steinhoff, Christine, et al.. (2015). Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation. Tumor Biology. 36(5). 3293–3300. 27 indexed citations
10.
Costa, Marta D., Joana B. Pereira, Maria Pala, et al.. (2013). A substantial prehistoric European ancestry amongst Ashkenazi maternal lineages. Nature Communications. 4(1). 2543–2543. 64 indexed citations
11.
Hatina, Jiřı́ & Wolfgang A. Schulz. (2012). Stem cells in the biology of normal urothelium and urothelial carcinoma. Neoplasma. 59(6). 728–736. 43 indexed citations
12.
Hatina, Jiřı́. (2012). The dynamics of cancer stem cells. Neoplasma. 59(6). 700–707. 28 indexed citations
13.
Zeimet, Alain G., Daniel Reimer, Sieghart Sopper, et al.. (2012). Ovarian cancer stem cells. Neoplasma. 59(6). 747–755. 44 indexed citations
14.
Hader, Christiane, et al.. (2009). DKC1 overexpression associated with prostate cancer progression. British Journal of Cancer. 101(8). 1410–1416. 98 indexed citations
15.
Hatina, Jiřı́, Wolfgang A. Schulz, Johannes Fischer, et al.. (2007). Tumorstammzellen - ein neues Konzept in der Tumorbiologie. DMW - Deutsche Medizinische Wochenschrift. 132(31/32). 1629–1632. 7 indexed citations
16.
Seifert, Hans‐Helge, Marcus V. Cronauer, Jiřı́ Hatina, et al.. (2007). A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder. World Journal of Urology. 25(3). 297–302. 22 indexed citations
17.
Pereira, Luı́sa, Martin Richards, Ana Goios, et al.. (2005). High-resolution mtDNA evidence for the late-glacial resettlement of Europe from an Iberian refugium. Genome Research. 15(1). 19–24. 136 indexed citations
18.
Jansa, Petr & Jiřı́ Hatina. (2003). The Inverted CCAAT Motif is an Indispensable Element of the Enhancer B of the Mouse Major Histocompatibility I H2-K b Gene. DNA and Cell Biology. 22(1). 55–64. 2 indexed citations
19.
Hatina, Jiřı́, et al.. (2002). Transcription Factor NF-IL6 (C/EBP β ) Activates the Expression of the Mouse MHC Class I H2-K b Gene in Response to TNF- α via the Intragenic Downstream Regulatory Element. Journal of Interferon & Cytokine Research. 22(7). 741–749. 4 indexed citations
20.
Hatina, Jiřı́. (1999). Lymphoid specificity of a copy number-related expression of the H2-Kb transgene. Molecular Immunology. 36(1). 73–80. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda J. Russell Breakdown of academic impact, for papers by Raed Samara Breakdown of academic impact, for papers by Gillian Hutchinson Breakdown of academic impact, for papers by Patricia F. van Kuijk Breakdown of academic impact, for papers by David N. Boone Breakdown of academic impact, for papers by Nobuaki Akakura Breakdown of academic impact, for papers by Ulrike Schwarz‐Boeger Breakdown of academic impact, for papers by René Figueredo Breakdown of academic impact, for papers by Amel Saadi Breakdown of academic impact, for papers by Christiane Hader
Rankless by CCL
2026